X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218204
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-6-2023-46648.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217166
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217789
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://health.economictimes.indiatimes.com/news/pharma/usfda-approves-alembics-ketorolac-tromethamine-injection-usp/95276190
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214456
https://www.raps.org/news-and-articles/news-articles/2022/10/fda-warns-us-sterile-injectable-maker-on-contamina
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217038
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216651
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-24-2022-1661335123.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215788
https://www.fiercepharma.com/manufacturing/fresenius-kabi-pulls-anti-inflammation-drug-ketorolac-over-particulate-fears-again
https://endpts.com/recall-report-fresenius-kabi-yanks-inflammatory-med-ketorolac-after-finding-particulates-in-vials/
https://www.pharmacompass.com/pdf/news/fresenius-kabi-issues-voluntary-nationwide-recall-of-ketorolac-tromethamine-injection-1610173486.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-6-2021-1609918562.pdf
https://www.prnewswire.com/news-releases/nephron-announces-fda-approval-of-ketorolac-signaling-new-phase-of-growth-301197581.html
https://www.prnewswire.com/news-releases/nephron-announces-fda-approval-of-ketorolac-signaling-new-phase-of-growth-301197581.html
https://www.globenewswire.com/news-release/2020/10/21/2111830/0/en/Neumentum-and-Nuance-Biotech-Enter-into-Licensing-Agreement-for-NTM-001-ketorolac-for-IV-infusion-in-China.html#:~:text=MORRISTOWN%2C%20N.J.%2C%20Oct.%2021,China%20based%20specialty%20pharmaceutical%20company%2C
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211445
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-17-2020-1592377204.pdf
https://www.pharmacompass.com/pdf/news/fresenius-kabis-recall-of-ketorolac-results-in-quva-pharma-recall-of-compounded-sterile-product-reck-1588048740.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213515
https://www.pharmacompass.com/pdf/news/fresenius-kabi-issues-voluntary-nationwide-recall-of-13-lots-of-ketorolac-tromethamine-1587446487.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213515
https://www.pharmacompass.com/pdf/news/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-of-ketorolac-tromethamine-1583492070.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-19-2020-1582176609.pdf
https://www.prnewswire.com/news-releases/promising-results-from-human-pk-study-assessing-novel-ketorolac-formulations-for-treatment-of-pain-300995130.html
https://www.pharmacompass.com/pdf/news/union-quimico-farmaceutica-fails-edqm-inspection-1572404101.pdf
https://www.fiercebiotech.com/biotech/j-j-offloads-midphase-pain-program-to-neumentum
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207204
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203492
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-ketorolac-tromethamine-injection-usp
https://www.prnewswire.com/news-releases/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-of-ketorolac-tromethamine-injection-usp-60mg2ml-30mg-per-ml-due-to-lack-of-sterility-assurance-300841362.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203410
https://www.pharmacompass.com/pdf/news/Enforcement-Report-for-Week-of-February-20-2019-1550644123.pdf
https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm626326.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205191
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-October-31-2018-1540974685.pdf
https://www.prnewswire.com/news-releases/neumentum-announces-dosing-of-patients-in-phase-i-study-evaluating-its-lead-product-candidate-ntm-001-a-non-opioid-in-development-for-the-management-of-moderately-severe-acute-pain-300708023.html
https://www.cnbc.com/2018/08/28/ketamine-acts-like-an-opioid-researchers-say.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210616
https://www.prnewswire.com/news-releases/egalet-announces-national-pharmacy-benefit-manager-to-cover-sprix-nasal-spray-and-arymo-er-300642983.html
https://www.prnewswire.com/news-releases/egalets-partner-orapharma-begins-promotion-of-sprix-nasal-spray-300586254.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf
Market Place
Share 
